Literature DB >> 28359030

Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.

Henning D Popp1, Nicole Naumann2, Susanne Brendel2, Thomas Henzler3, Christel Weiss4, Wolf-Karsten Hofmann2, Alice Fabarius2.   

Abstract

Increased DNA damage and alteration of the DNA damage response (DDR) are critical features of genetic instability presumably implicated in pathogenesis of myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML). We used immunofluorescence staining of γH2AX and 53BP1 for analyzing DNA double-strand breaks (DSB) in MDS and AML cell lines, in CD34+ selected cells of normal and MDS bone marrow (including three cases of chronic myelomonocytic leukemias) and in blasts of AML bone marrow. In addition, we screened for activation of the DDR by immunoblotting of p-ATM, p-ATR, p-CHK1, p-CHK2 and p-TP53. As compared to γH2AX foci levels in normal bone marrow samples (0.2 focus per CD34+ cell±0.0; mean±standard error of mean), increased levels of γH2AX foci were detected in 16/16 MDS bone marrow samples (2.8 foci per CD34+ cell±0.5), 18/18 AML bone marrow samples (5.5 foci per blast±0.5), 1/1 MDS cell line (6.4 foci per cell) and 6/6 AML cell lines (12.0 foci per cell±0.6). γH2AX and 53BP1 co-localized in all tested samples forming diffuse, clustered and marginal patterns. Further, DDR proteins were expressed heterogeneously suggesting impairment of the DDR. In summary, our results provide evidence for a continuous increase of DSB across the spectrum from MDS to AML in conjunction with an impaired DDR. Co-localization of γH2AX and 53BP1 indicates promotion of (in)effective nonhomologous end-joining repair mechanisms at sites of DSB. Moreover, γH2AX/53BP1 foci distribution presumably reveals a non-random spatial organization of the genome in MDS and AML.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemias; DNA damage response; DNA double-strand breaks; Genetic instability; Myelodysplastic syndromes

Mesh:

Substances:

Year:  2017        PMID: 28359030     DOI: 10.1016/j.leukres.2017.03.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  The DNA damage response pathway in normal hematopoiesis and malignancies.

Authors:  Domenico Delia; Shuki Mizutani
Journal:  Int J Hematol       Date:  2017-07-13       Impact factor: 2.490

2.  Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.

Authors:  Xin Zhao; Shouguo Gao; Zhijie Wu; Sachiko Kajigaya; Xingmin Feng; Qingguo Liu; Danielle M Townsley; James Cooper; Jinguo Chen; Keyvan Keyvanfar; Maria Del Pilar Fernandez Ibanez; Xujing Wang; Neal S Young
Journal:  Blood       Date:  2017-10-13       Impact factor: 22.113

Review 3.  Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells.

Authors:  Jialan Niu; Danyue Peng; Lingbo Liu
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

4.  Immunofluorescence Microscopy of γH2AX and 53BP1 for Analyzing the Formation and Repair of DNA Double-strand Breaks.

Authors:  Henning D Popp; Susanne Brendel; Wolf-Karsten Hofmann; Alice Fabarius
Journal:  J Vis Exp       Date:  2017-11-03       Impact factor: 1.355

5.  Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.

Authors:  Lingling Shi; Rui Huang; Yongrong Lai
Journal:  BMC Med Genomics       Date:  2021-05-13       Impact factor: 3.063

6.  Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.

Authors:  Molly K Imgruet; Julian Lutze; Ningfei An; Bonnie Hu; Saira Khan; Jeffrey Kurkewich; Tanner C Martinez; Donald Wolfgeher; Sandeep K Gurbuxani; Stephen J Kron; Megan E McNerney
Journal:  Blood       Date:  2021-09-02       Impact factor: 25.476

Review 7.  DNA Damage/Repair Management in Cancers.

Authors:  Jehad F Alhmoud; John F Woolley; Ala-Eddin Al Moustafa; Mohammed Imad Malki
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

8.  Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells.

Authors:  Vanessa Kohl; Oliver Drews; Victor Costina; Miriam Bierbaum; Ahmed Jawhar; Henning Roehl; Christel Weiss; Susanne Brendel; Helga Kleiner; Johanna Flach; Birgit Spiess; Wolfgang Seifarth; Daniel Nowak; Wolf-Karsten Hofmann; Alice Fabarius; Henning D Popp
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

9.  Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.

Authors:  Vanessa Kohl; Johanna Flach; Nicole Naumann; Susanne Brendel; Helga Kleiner; Christel Weiss; Wolfgang Seifarth; Daniel Nowak; Wolf-Karsten Hofmann; Alice Fabarius; Henning D Popp
Journal:  Cancers (Basel)       Date:  2019-10-03       Impact factor: 6.639

Review 10.  TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings.

Authors:  Cosimo Cumbo; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.